• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
✕
  • Home
  • News
  • Expert views
  • PolyPetide’s Approach to Process Intensification: Tackling the increasing Peptide Demand

PolyPetide’s Approach to Process Intensification: Tackling the increasing Peptide Demand

27 November 2025
Expert views

Presented at TIDES Europe, 12 November 2025

Speaker: Francesco Terzani, Scientist Innovation

Abstract: The global rise in peptide demand, driven by accelerated clinical development and speed to market pressures, requires a rethinking of traditional peptide manufacturing. Process Intensification (P.I.) provides a structured approach to increasing output, minimizing costs, with a focus on flexibility and sustainability. This presentation will highlight some P.I. tools as single-unit operations or in combinatorial scenario with other technologies under evaluation.

Back to news

Related posts

13 August 2025

Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis


Read more
2 April 2025

Expanding the Reach of Sustainable Solid-Phase Peptide Synthesis


Read more
20 March 2025

Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase


Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2025 PolyPeptide Group • Cookie Policy • Sitemap • Privacy policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers